Hypothetically, given the increased risk of severe COVID‐19 conferred by the TYK2 variant, its lower frequency on the island could in part, together with other COVID‐19 protecting variants, contribute to the protection against severe disease but decrease the general protection from autoimmunity, known to be common in Sardinia. The gene discussed is TYK2; the disease is COVID-19.